微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Goodfellowiella coeruleoviolacea |
|---|---|
| 商品货号： | TS134568 |
| Deposited As： | Unidentified bacterium |
| Strain Designations： | Q996-17 |
| Application： | Produces epoxomicin |
| Isolation： | Soil, Andhra Pradesh State, India |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1877: ISP Medium 1 ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor： | Bristol-Myers Squibb Co. |
| U.S. Patent Number： | |
| References： | Hanada M, et al. Epoxomicin, a new antitumor agent of microbial origin. J. Antibiot. 45: 1746-1752, 1992. PubMed: 1468981 |